Chemical Compound
Stanozolol; 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-; 2'H-5alpha-Androst-2-eno[3,2-c]pyrazol-17beta-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl- (6CI,7CI); (5alpha,17beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol; 17-Methyl-5alpha-androstano[3,2-c]pyrazol-17beta-ol; 17-Methyl-pyrazolo[4',3':2,3]-5alpha-androstan-17beta-ol; 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole; 17beta-Hydroxy-17-methyl-5alpha-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC 233046; NSC 43193; Stanabolic; Stanazolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V
CAS Registry Number
10418-03-8
Primary record
Stanozolol; 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-; 2'H-5alpha-Androst-2-eno[3,2-c]pyrazol-17beta-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl- (6CI,7CI); (5alpha,17beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol; 17-Methyl-5alpha-androstano[3,2-c]pyrazol-17beta-ol; 17-Methyl-pyrazolo[4',3':2,3]-5alpha-androstan-17beta-ol; 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole; 17beta-Hydroxy-17-methyl-5alpha-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC 233046; NSC 43193; Stanabolic; Stanazolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V
- 库存
- 9,639 克
- 纯度
- 99.8 %
- CAS
- 10418-03-8
化合物标识与属性
- CAS
- 10418-03-8
- PubChem CID
- 25249
- SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C
- Canonical SMILES
- C[C@]12Cc3cn[nH]c3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
名称与同义词
- stanozolol
- Winstrol
- Androstanazole
- Androstanazol
- Stromba
- Stanazolol
- Tevabolin
- Strombaject
- Winstrol Depot
- Estazol
- Estanozolol
- Winstroid
- Winstrol V
- Stanozololum
- Anabol
- Methylstanazol
- Stanozolol ciii
- Stanozolo
- stanozol
- stanozololo
- Winstrol-V
- Stanozolo [DCIT]
- Stanozolol CRS
- Stanozolol powder
- Androstanazole (VAN)
- 10418-03-8
- Androstanazolestanazol
- Winstrol (TN)
- Winstrol-V Tablets
- Stanozolol degrees
- Stanozolol (1'H form)
- Winstrol|||Stanabol
- Stanozololum [INN-Latin]
- WIN 14833
- Estanozolol [INN-Spanish]
- Stanozolol (2'H form)
- RefChem:6260
- A1IOS
- STANOZOLOL [MI]
- DTXSID3044128
- STANOZOLOL [INN]
- STANOZOLOL [JAN]
- 4R1VB9P8V3
- STANOZOLOL [HSDB]
- STANOZOLOL [USAN]
- UNII-4R1VB9P8V3
- NSC-43193
- STANOZOLOL [VANDF]
- WIN-14833
- D08QKJ
- HSDB 3185
- AC1L18QU
- STANOZOLOL [MART.]
- CHEBI:9249
- Winstrol-V Chewable Tablets
- STANOZOLOL [WHO-DD]
- stanozolol--dea schedule iii
- DEA No. 4000
- SCHEMBL44099
- SCHEMBL44101
- DTXCID1024128
- Stanozolol (JAN/USP/INN)
- C21H32N2O
- MLS001424321
- Winstrol-V Sterile Suspension
- EINECS 233-894-8
- LKAJKIOFIWVMDJ-IYRCEVNGSA-N
- NSC 43193
- Stanozolol, analytical standard
- AC1Q59E2
- Stanozolol [USAN:BAN:INN:JAN]
- STANOZOLOL [GREEN BOOK]
- C21H32N2O.CH4
- CHEMBL2079587
- NSC 233046
- NSC-233046
- NSC43193
- STANOZOLOL [ORANGE BOOK]
- WIN14833
- GTPL10369
- A14AA02
- STANOZOLOL [EP MONOGRAPH]
- STANOZOLOL CIII [USP-RS]
- GLXC-10566
- HMS2052H11
- HMS2090P03
- HMS3713K06
- STANOZOLOL [USP MONOGRAPH]
- Stanozolol [USAN:INN:BAN:JAN]
- BCP12548
- CID25249
- HY-B0899
- Stanozolol [USAN:USP:INN:BAN:JAN]
- Stanozolol, 1mg/ml in Acetonitrile
- ZINC4097376
- Tox21_113993
- C21-H32-N2-O
- CID:25249
- MFCD00133084
- MSK8501-100A
- NSC233046
- AKOS005067278
- MSK8501-1000A
- Stanozolol 1.0 mg/ml in Acetonitrile
- ACN-031989
- AM84316
- CCG-101186
- CCG-220452
- CS-4363
- CS-O-02374
- DB06718
- EBD2201785
- J3.432K
- NC00436
- NCGC00344550-01
- 17-Methyl-5alpha-androstano(3,2-c)pyrazol-17beta-ol
- AC-16140
- AC-33164
- AS-35198
- BC210011
- CPD000058878
- FS156771
- LS-19415
- LS-19530
- SID:53790969
- SMR000058878
- 17-Methyl-2'H-5alpha-androst-2-eno(3,2-c)pyrazol-17beta-ol
- CAS-10418-03-8
- J332.003K
- TL8000176
- 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole
- FT-0701712
- NS00008736
- 17-beta-Hydroxy-17-alpha-methylandrostano(3,2-c)pyrazole
- 17beta-Hydroxy-17alpha-methyl-androstano(3,2-c)pyrazole
- 2'H-5alpha-Androst-2-eno(3,2-c)pyrazol-17beta-ol, 17-methyl-
- 2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
- C07311
- D00444
- Stanozolol Solution in Acetonitrile, 100ug/mL
- 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol
- 17-Methyl-pyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
- 17-Methylpyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
- AB00443942-03
- AB00443942-05
- Stanozolol Solution in Acetonitrile, 1000ug/mL
- 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole
- 418S038
- D013197
- SR-05000001522
- 2,3-(4',3'-Pyrazolo)-5alpha-androstan-17beta-ol, 17-methyl-
- I06-2218
- SR-05000001522-1
- SR-05000001522-2
- 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole
- 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole
- 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole
- BRD-K46791647-001-01-2
- Q63409446
- (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol
- (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
- 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol
- Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
- Stanozolol, European Pharmacopoeia (EP) Reference Standard
- (5a,17b)-17-methyl-2'H-Androst-2-eno[3,2-c]pyrazol-17-ol
- 1'H-Androstano(3,2-c)pyrazol-17-ol, 17-methyl-, (5-alpha,17-beta)-
- 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-Hexadecahydro-1,10a,12a-trimethylcyclopenta(7,8)-phenanthro(2,3-c)pyrazol-1-ol
- 17-Methyl-1 H-5alpha-androstano[3,2-c]pyrazol-17beta-ol
- 2,3'-Pyrazolo)-5.alpha.-androstan-17.beta.-ol, 17-methyl-
- 302-96-5
- 17-Methyl-2 H-5alpha-androst-2-eno[3,2-c]pyrazol-17beta-ol
- 17-Methyl-2'H-5.alpha.-androst-2-eno(3,2-c)pyrazol-17.beta.-ol
- 17-METHYL-5.ALPHA.-ANDROSTANO(3,2-C)PYRAZOL-17.BETA.-OL
- 2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI)
- Cyclopenta[7,8]phenanthro-[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4
- (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
- (5-alpha,17-beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol
- 1'H-ANDROSTANO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5alpha,17beta)-
- 1'H-Androstano[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
- 17966-55-1
- 17alpha-Methyl-17beta-hydroxy-5alpha-androst-2-eno(3,2-c)-pyrazole
- 17alpha-Methyl-2 H-5alpha-androst-2-eno[3,2-c]pyrazol-17beta-ol
- 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
- Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
- 1'H-ANDROSTANO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5.ALPHA.,17.BETA.)-
- 17.BETA.-HYDROXY-17.ALPHA.-METHYL-5.ALPHA.-ANDROSTANO(3,2-C)PYRAZOLE
- 2'H-ANDROST-2-ENO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5.ALPHA.,17.BETA.)
- 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
- Cyclopenta[7,8]phenanthro[2,3-c]pyrazole, 2'H-androst-2-eno[3,2-c]pyrazol-17-ol deriv.
- (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo(11.7.0.0^(2,10).0^(4,8).0^(14,18))icosa-4(8),5-dien-17-ol
- (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4(8),5-dien-17-ol
- (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4,7-dien-17-ol
- 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol
- 233-894-8
- Cyclopenta[7,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
- Stanozolol; 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-; 2'H-5alpha-Androst-2-eno[3,2-c]pyrazol-17beta-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl- (6CI,7CI); (5alpha,17beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol; 17-Methyl-5alpha-androstano[3,2-c]pyrazol-17beta-ol; 17-Methyl-pyrazolo[4',3':2,3]-5alpha-androstan-17beta-ol; 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole; 17beta-Hydroxy-17-methyl-5alpha-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC 233046; NSC 43193; Stanabolic; Stanazolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V